NRx Pharmaceuticals (NRXP) Reports In-Line Q1 EPS

NRx Pharmaceuticals (NASDAQ: NRXP) reported Q1 EPS of $0.00. Revenue for the quarter came in at $1.07 million.

For earnings history and earnings-related data on NRx Pharmaceuticals (NRXP) click here.

You May Also Be Interested In

• Netflix climbs following Ackman stake, up 1.8%
• Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77
• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance